Φορτώνει......
SUN-413 Dual Endocrinopathies Following Single Dose of Pembrolizumab Therapy
Introduction: Immune related endocrine adverse effects (IReAs) caused by checkpoint inhibitors (CI) used in the treatment of advanced cancers are rare and often under recognized, but they can be potentially life-threatening. Case: A 69 y/o male with stage 4 metastatic colon cancer was evaluated 10 d...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Endocr Soc |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Endocrine Society
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552853/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-413 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|